Skip to content
10-K

Annual Report

Cellcyte Genetics Corp.

0001056520-12-000153

← back to feed
Filed
Apr 16, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Apr 13, 2012 82.33M sh
Operating Cash Flow FY 2011 · Dec 31, 2011 −$5.92M
Operating Cash Flow FY 2011 · Dec 31, 2010 −$80.23K
Sga Expense FY 2011 · Dec 31, 2011 $2.53M
Sga Expense FY 2011 · Dec 31, 2010 $177.17K
Rd Expense FY 2011 · Dec 31, 2011 $1.3M
Long Term Debt FY 2011 · Dec 31, 2010 $273.54K
Current Liabilities FY 2011 · Dec 31, 2010 $916.75K
Current Assets FY 2011 · Dec 31, 2010 $10.05K
Total Assets FY 2011 · Dec 31, 2010 $56.47K
Cash And Equivalents FY 2011 · Dec 31, 2009 $7.3K